WO2014068092A3 - Verfahren zur geschlechtsunabhängigen bestimmung von alterung - Google Patents

Verfahren zur geschlechtsunabhängigen bestimmung von alterung Download PDF

Info

Publication number
WO2014068092A3
WO2014068092A3 PCT/EP2013/072878 EP2013072878W WO2014068092A3 WO 2014068092 A3 WO2014068092 A3 WO 2014068092A3 EP 2013072878 W EP2013072878 W EP 2013072878W WO 2014068092 A3 WO2014068092 A3 WO 2014068092A3
Authority
WO
WIPO (PCT)
Prior art keywords
subject
sex
invention further
expression level
further relates
Prior art date
Application number
PCT/EP2013/072878
Other languages
English (en)
French (fr)
Other versions
WO2014068092A2 (de
Inventor
Eugenia MAKRANTONAKI
Christos C. Zouboulis
James ADJAYE
Original Assignee
Makrantonaki Eugenia
Zouboulis Christos C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Makrantonaki Eugenia, Zouboulis Christos C filed Critical Makrantonaki Eugenia
Priority to KR1020157012716A priority Critical patent/KR20150094601A/ko
Priority to CN201380057252.1A priority patent/CN104797719A/zh
Priority to US14/439,639 priority patent/US20150284795A1/en
Priority to EP13802255.3A priority patent/EP2914746A2/de
Publication of WO2014068092A2 publication Critical patent/WO2014068092A2/de
Publication of WO2014068092A3 publication Critical patent/WO2014068092A3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung bezieht sich auf ein Verfahren zur Bestimmung des Alterungszustandes eines Subjekts. Das Verfahren erlaubt es, ausgehend von bestimmten Nukleinsäuren oder Proteinen und deren Expressionslevel Rückschlüsse auf das Alter und mit dem Alter verbundene Zustände eines Subjektes – auch unabhängig vom Geschlecht – zu ziehen. Die vorliegende Erfindung betrifft außerdem eine Gruppe von Genen, deren Expressionslevel vom Alterungszustand des jeweiligen Subjekts – auch unabhängig vom Geschlecht – abhängt. Darüber hinaus betrifft die Erfindung die Bestimmung des Expressionslevels der Gene sowie die Benutzung der entsprechenden Expressionslevel zur Bestimmung von Alterungszuständen. Diese Erfindung betrifft auch Vorrichtungen, insbesondere Arrays und Chips, die zur Bestimmung des Alterungszustandes eines Subjekts eingesetzt werden können.
PCT/EP2013/072878 2012-11-01 2013-11-01 Verfahren zur geschlechtsunabhängigen bestimmung von alterung WO2014068092A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020157012716A KR20150094601A (ko) 2012-11-01 2013-11-01 성별에 독립적인 연령 결정 방법
CN201380057252.1A CN104797719A (zh) 2012-11-01 2013-11-01 用于不取决于性别的确定老化的方法
US14/439,639 US20150284795A1 (en) 2012-11-01 2013-11-01 Method for determining age independently of sex
EP13802255.3A EP2914746A2 (de) 2012-11-01 2013-11-01 Verfahren zur geschlechtsunabhängigen bestimmung von alterung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012110469.7A DE102012110469A1 (de) 2012-11-01 2012-11-01 Verfahren zur geschlechtsunabhängigen Bestimmung von Alterung
DE102012110469.7 2012-11-01

Publications (2)

Publication Number Publication Date
WO2014068092A2 WO2014068092A2 (de) 2014-05-08
WO2014068092A3 true WO2014068092A3 (de) 2014-06-26

Family

ID=49726698

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/072878 WO2014068092A2 (de) 2012-11-01 2013-11-01 Verfahren zur geschlechtsunabhängigen bestimmung von alterung

Country Status (6)

Country Link
US (1) US20150284795A1 (de)
EP (1) EP2914746A2 (de)
KR (1) KR20150094601A (de)
CN (1) CN104797719A (de)
DE (1) DE102012110469A1 (de)
WO (1) WO2014068092A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108949771B (zh) * 2018-08-02 2021-10-19 南京农业大学 拟环纹豹蛛c家族杀虫基因及其编码的成熟肽与应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013610A2 (en) * 1994-10-31 1996-05-09 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes
WO2001053472A2 (en) * 2000-01-21 2001-07-26 Polymun Scientific Immunbiologische Forschung Gmbh Tumor and senescence marker
WO2002004662A1 (en) * 2000-07-06 2002-01-17 Lifespan Biosciences, Inc. Proteins associated with aging
WO2002074911A2 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
WO2006036943A2 (en) * 2004-09-27 2006-04-06 The University Of North Carolina At Chapel Hill Determination of molecular age by detection of ink4a/arf expression
US20120040855A1 (en) * 2009-03-11 2012-02-16 Yuanlong Pan Tissue-specific aging biomarkers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5311439B2 (ja) * 2006-12-27 2013-10-09 日本メナード化粧品株式会社 皮膚の状態を評価する方法及びその用途

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013610A2 (en) * 1994-10-31 1996-05-09 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes
WO2001053472A2 (en) * 2000-01-21 2001-07-26 Polymun Scientific Immunbiologische Forschung Gmbh Tumor and senescence marker
WO2002004662A1 (en) * 2000-07-06 2002-01-17 Lifespan Biosciences, Inc. Proteins associated with aging
WO2002074911A2 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
WO2006036943A2 (en) * 2004-09-27 2006-04-06 The University Of North Carolina At Chapel Hill Determination of molecular age by detection of ink4a/arf expression
US20120040855A1 (en) * 2009-03-11 2012-02-16 Yuanlong Pan Tissue-specific aging biomarkers

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JACOB M ZAHN ET AL: "AGEMAP: a gene expression database for aging in mice", PLOS GENETICS, PLOS, vol. 3, no. 11, 30 November 2007 (2007-11-30), pages 2326 - 2337, XP008153921, ISSN: 1533-7390, DOI: 10.1371/JOURNAL.PGEN.0030201 *
LEE C-K ET AL: "Gene expression profile of aging and its retardation by caloric restriction", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 285, no. 5432, 27 August 1999 (1999-08-27), pages 1390 - 1393, XP002341761, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.285.5432.1390 *
THORE C BRINK ET AL: "Age-related transcriptional changes in gene expression in different organs of mice support the metabolic stability theory of aging", BIOGERONTOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 10, no. 5, 23 November 2008 (2008-11-23), pages 549 - 564, XP019727542, ISSN: 1573-6768 *
WEINDRUCH R ET AL: "Gene expression profiling of aging using DNA microarrays", MECHANISMS OF AGEING AND DEVELOPMENT, ELSEVIER SEQUOIA, LAUSANNE, CH, vol. 123, 1 January 2002 (2002-01-01), pages 177 - 193, XP002304151, ISSN: 0047-6374, DOI: 10.1016/S0047-6374(01)00344-X *
ZAHN J.M. ET AL.: "Supplementary Table 1. Aging coefficients and p-values of 8932 genes in 16 mouse tissues.", 30 November 2007 (2007-11-30), XP002720215, Retrieved from the Internet <URL:http://cmgm.stanford.edu/~kimlab/aging_mouse/> [retrieved on 20140212] *

Also Published As

Publication number Publication date
WO2014068092A2 (de) 2014-05-08
DE102012110469A1 (de) 2014-05-08
EP2914746A2 (de) 2015-09-09
CN104797719A (zh) 2015-07-22
KR20150094601A (ko) 2015-08-19
US20150284795A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2019005199A (es) Métodos para evaluar el riesgo usando and libre de células total y específico.
WO2014150300A3 (en) Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits
WO2017020023A3 (en) Nucleic acids and methods for detecting chromosomal abnormalities
WO2017091811A3 (en) Methods for variant detection
EA201792389A1 (ru) Пцр в реальном времени для мультиплексной оптимизированной амплификации с несоответствиями (moma) и для оценки неклеточной днк
DK2831241T3 (da) Kunstige nukleinsyremolekyler til forbedret protein- eller peptidekspression.
EP3172341A4 (de) Verfahren zur bestimmung von gewebe- und/oder zelltypen zur entstehung von zellfreier dna und verfahren zur identifizierung einer krankheit oder störung damit
WO2013036929A8 (en) Methods for obtaining a sequence
WO2014197568A3 (en) Rna-guideded transcriptional regulation
WO2014066533A3 (en) Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
HK1201886A1 (zh) 同時確定胎兒核酸含量和染色體非整倍性的方法及裝置
WO2012094580A3 (en) Compounds that modulate oxidative stress
BR112018005411A2 (pt) sabor derivado de parede celular de levedura.
WO2016065349A8 (en) Short non-coding protein regulatory rnas (sprrnas) and methods of use
WO2014022826A3 (en) Biomarker associated with risk of melanoma reoccurrence
WO2014005969A9 (fr) Procede et dispositif pour la detection rapide de sequences nucleotidiques amplifiees
BR112015008621A2 (pt) Métodos e kit de diagnóstico e/ou prognóstico in vitro microconjunto de ácidos nucleicos.
EP3216852A4 (de) Verfahren zum einbringen von nukleinsäure, verfahren zur erkennung von nukleinsäure, verfahren zur analyse eines biologischen bestandteils, arrayvorrichtung zum testen eines biologischen bestandteils und kit zur analyse eines biologischen bestandteils
EP3307164A4 (de) Stabilisierte laktatsensitive enzyme, elektroden und sensoren sowie verfahren zur herstellung und verwendung davon
SG11201602686YA (en) Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species
EP3012326A4 (de) Primer und sondenset zur identifizierung von genpolymorphismus und verwendung davon
WO2014145870A3 (en) Novel compositions, methods and kits for blood typing
MX2017013980A (es) Metodo y composiciones de deteccion y cuantificacion de acido nucleico.
WO2014118643A3 (en) Methods of inducing responsiveness to anti-angiogenic agent
BR112015010427A2 (pt) compressor com equilíbrio de impulso e método do mesmo.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13802255

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14439639

Country of ref document: US

ENP Entry into the national phase

Ref document number: 20157012716

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013802255

Country of ref document: EP